Industry reports
Editor highlights

Pharmaceutical Industry in Japan: Market Research Reports, Statistics and Analysis

You might be interested in: drug, clinical trial, medicine, more »

» View Public Reports

About 800 reports

Pharmaceutical in Japan and The United Kingdom : Innovation and Technology Trends

  • Industry report
  • December 2013
  • 22 pages
  • by Corporation

... arthritis diabetes high satisfaction with treatment diseases with high contribution from medications diabetes complication alzheimer's disease presence of unmet medical needs low ...

Pharmaceutical in Japan and Ukraine : Innovation and Technology Trends

  • Industry report
  • September 2013
  • 24 pages

... Of nanohydrooxyapatite. The venture business was established for the applied research. Activity the example of the development of pharmaceutical products to use for bnct therapeutic method. Activity the example of drug ...

The Japanese Pharmaceutical Industry Brief

  • Industry report
  • February 2013
  • 15 pages
  • by Intergovernmental Agency

Pharmaceutical Market Analysis in Japan

  • Industry report
  • December 2012
  • 56 pages
  • by Corporation

... Deadly disease if not caught early diabetes glp1 agonist - albiglutide dr moncef slaoui albiglutide is not approved as a treatment for type 2 diabetes or any other indication anywhere in the world ...

Pharmaceutical Market Trends in The United States and Japan

  • Industry report
  • October 2012
  • 74 pages

... Such as stroke, peripheral artery disease and arterial aneurysms. - Holdt and teupser et al. Arterioscler thromb vasc biol. 2012;32:196 The fact that a major proportion of the susceptibility to cad ...

Pharmaceutical Market in Japan and France

  • Industry report
  • September 2012
  • 19 pages

... International childhood cancer cohort consortium (i4c) workshop on november 12-13, 2012 In lyon, france Physical development: low birth weight, development after birth, etc. Physical development: low ...

Pharmaceutical Industry Analysis in The United States and Japan

  • Industry report
  • August 2012
  • 187 pages
  • by Corporation

... Key planned product launches tissue diagnostics product description region er test estrogen receptor antibody (ihc) assay to support the diagnosis of breast cancer us cintec p16 cytology ...

Pharmaceutical Sector Analysis in The United States and Japan

  • Industry report
  • August 2012
  • 187 pages
  • by Corporation

... Metabolic diseases infectious diseases prevention cytomegalovirus disease in kidney transplant recipients phase/study phase iiequator phase i phase ii # of patients n=224 n=181 n=110 design sc dosing every 4 ...

Pharmaceutical Business Analysis in The United States and Japan

  • Industry report
  • August 2012
  • 187 pages
  • by Corporation

... Metabolic diseases infectious diseases prevention cytomegalovirus disease in kidney transplant recipients phase/study phase iiequator phase i phase ii # of patients n=224 n=181 n=110 design sc dosing every 4 ...

Pharmaceutical Market Analysis in The United States and Japan

  • Industry report
  • August 2012
  • 187 pages
  • by Corporation

... Metabolic diseases infectious diseases prevention cytomegalovirus disease in kidney transplant recipients phase/study phase iiequator phase i phase ii # of patients n=224 n=181 n=110 design sc dosing every 4 ...


» Purchase Premium Reports (From $ 125 - $ 4 995)

About 1 800 reports
PharmaPoint: Migraine - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Migraine - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Migraine - Japan Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected ...

Pharmapoint: Schizophrenia - Japan Drug Forecast And Ma ...

February 2014 $ 4 995

Pharmapoint: Crohn's Disease - Japan Drug Forecast And ...

January 2014 $ 4 995

Pharmapoint: Prophylactic Hepatitis B Virus Vaccines - ...

January 2014 $ 4 995

Epicast Report: Allergic Rhinitis - Epidemiology Foreca ...

April 2014 $ 3 995

Epicast Report: Ankylosing Spondylitis - Epidemiology F ...

March 2014 $ 3 995

Epicast Report: Major Depressive Disorder - Epidemiolog ...

February 2014 $ 3 995

Epicast Report: Migraine - Epidemiology Forecast To 202 ...

February 2014 $ 3 995

Pancreatic Adenocarcinoma Therapeutics In Major Develop ...

April 2014 $ 3 500

Epilepsy Therapeutics In Asia Pacific Markets To 2019 - ...

March 2014 $ 3 500

» Read our Company Profiles

1 Companies

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.